author-photo

Jay M. Short

Stratagene
Case Western Reserve University

95

Papers

9018

Citations

Citation Trend

Filter By

Papers (95) Sort By

Journal Conference Others

Abstract 1870: Novel conditionally active bispecific T cell engagers targeting solid tumors

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 694: Novel conditionally active bispecific EpCAM x CD3 T cell engagers targeting solid tumors

2021
Show All
- Source
- Cite
- Save
Citations (0)
Multipurpose Cloning Vectors

2021
Show All
- Source
- Cite
- Save
Citations (0)
Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.

2021 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 5698: Novel conditionally active bispecific T cell engagers targeting solid tumors

2020
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4560: Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors

2020 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2708: Potent CAB CTLA4 antibody to reduce immune side effects and toxicities associated with single-agent and combination cancer immuno therapies

2019 Immunology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 356: Novel conditionally active biologic (CAB) antibody targeting EpCAM demonstrates anti-tumor efficacy in vivo

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)